Výsledky vyhledávání - "Denise Wolko"

Efficacy and safety of long‐acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgery

Autor: Yanyan Li, Anne Lienhart, Claude Negrier, Iris Jacobs, Elena Santagostino, Lynda Mae Lepatan, M. F. López‐Fernández, F. Abdul Karim, Christine Voigt, Johnny Mahlangu, Denise Wolko, Ingrid Pabinger

Publikováno v: Haemophilia. 22

Introduction Recombinant factor IX fusion protein (rIX-FP) has been developed to improve the pharmacokinetic (PK) profile of factor IX (FIX), allowing maintenance of desired FIX activity between injections at extended intervals, ultimately optimizing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::517375cc92008d138f84f1718aacbd31
https://doi.org/10.1111/hae.12972

Zobrazit plný text záznamu

Efficacy and Safety of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B Undergoing Major Orthopedic Surgeries

Autor: Elena Santagostino, Christine Voigt, Iris Jacobs, Denise Wolko, Anne Lienhart, Faralzah Karim, Lynda Mae Lepatan, Claude Negrier

Publikováno v: Blood. 126:2298-2298

A fusion protein genetically linking recombinant human coagulation FIX with recombinant human albumin (rIX-FP) has been developed with an improved PK profile, improving hemophilia B treatment by allowing less frequent dosing and FIX consumption for p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cd8aa7acbad592077d4de0c7712a97e4
https://doi.org/10.1182/blood.v126.23.2298.2298

Zobrazit plný text záznamu

Efficacy and Safety Results of Prolong-9FP Clinical Program of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B

Autor: Elena Santagostino, Iris Jacobs, Grace Cole, Christine Voigt, Yanyan Li, Denise Wolko

Publikováno v: Blood. 126:548-548

A fusion protein genetically linking recombinant human coagulation FIX with recombinant human albumin (rIX-FP) has been developed with an improved PK profile, thus improving hemophilia B treatment by allowing less frequent dosing. Two Phase 3 studies

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b8ecd6fdacf587b51f0ea4ead32baa76
https://doi.org/10.1182/blood.v126.23.548.548

Zobrazit plný text záznamu

Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program

Autor: Elena Santagostino, Iris Jacobs, Toshko Lissitchkov, Christine Voigt, Aaron Lubetsky, Denise Wolko, Uri Martinowitz

Publikováno v: Blood. 126:1096-1096

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1f8cce2661a8402026b88f5a3ec271a2
https://doi.org/10.1182/blood.v126.23.1096.1096

Zobrazit plný text záznamu

The Safety of an Adenosine A(1)-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment Findings from PROTECT

Publikováno v: ResearcherID
Drug Safety, 35(3), 233-244. ADIS INT LTD

Background: Adenosine exerts actions in multiple organ systems, and adenosine receptors are a therapeutic target in many development programmes.Objective: The aim of this analysis was to evaluate the safety of rolofylline, an adenosine A(1)-receptor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0a079bd3c3c8c8996569748a476911d
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000301618100005&KeyUID=WOS:000301618100005

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání